Glaxo's Bid for Human Genome Is a Positive for Anthera Pharma (ANTH) - Analyst

Go back to Glaxo's Bid for Human Genome Is a Positive for Anthera Pharma (ANTH) - Analyst
ANTHERA PHARMA (AMEX: ANTH) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High $6.08 
Open $0.00    52 Week Low $1.72 
Day High $0.00    P/E 0.00 
Day Low $0.00    EPS $-1.47 
Volume 24,452       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 49.52 -0.48 (0.96%)
Previous Close $50.00    52 Week High $45.58 
Open $49.04    52 Week Low $37.82 
Day High $49.57    P/E N/A 
Day Low $48.86    EPS $0.00 
Volume 3,722,991       

Human Genome Sciences, Inc. (NASDAQ: HGSI) Delayed: 14.24 --0 (-0%)
Previous Close $14.24    52 Week High $16.58 
Open $55.80    52 Week Low $6.51 
Day High $14.24    P/E N/A 
Day Low $14.24    EPS $-1.79 
Volume 557,147